Category: Uncategorized

SK Life Science Labs to present new preclinical data on targeted protein degradation at AACR 2026

18/04/2026 Published by vivi

At the American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego, SK Life Science Labs, a subsidiary... Read more

Tags: #Global Trends

MSN Laboratories launches Semabest Semaglutide in India to enhance affordability

18/04/2026 Published by vivi

MSN Laboratories has officially introduced Semabest, its domestic semaglutide brand, to the Indian market following approval from the Central Drugs... Read more

Category: Uncategorized

Tags: #Global Trends

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Partner to Advance ADC Manufacturing

18/04/2026 Published by vivi

Piramal Pharma Solutions (India) and Ajinomoto Bio-Pharma Services (Japan) have announced a strategic collaboration to enhance the development and manufacturing... Read more

Category: Uncategorized

Tags: #Global Trends

European Commission approves Merck’s ENFLONSIA™ (clesrovimab) for infant RSV prevention

18/04/2026 Published by vivi

The European Commission (EC) has officially granted marketing authorization for ENFLONSIA™ (clesrovimab), a long-acting monoclonal antibody developed by Merck (MSD)... Read more

Category: Uncategorized

Tags: #Global Trends

Bayer’s FXIa inhibitor asundexian reduces ischemic stroke risk without increasing major bleeding

18/04/2026 Published by vivi

Bayer has announced the publication of full results from the Phase III OCEANIC-STROKE study in The New England Journal of... Read more

Category: Uncategorized

Tags: #Global Trends

UCB pivots to cell therapy with $1.2B acquisition of Neurona Therapeutics

18/04/2026 Published by vivi

Belgian pharmaceutical giant UCB announced on Friday its acquisition of Neurona Therapeutics for up to $1.2 billion. The move highlights... Read more

Category: Uncategorized

Tags: #M&A

Implementation of the new sanction framework to tighten administrative management in healthcare

18/04/2026 Published by vivi

The Ministry of Health has recently issued an implementation plan for Decree No. 90/2026/ND-CP (signed on March 30, 2026) regarding... Read more

Category: Uncategorized

Tags: #Vietnam

Vir Biotechnology completes Astellas deal to advance prostate cancer immunotherapy

18/04/2026 Published by vivi

Vir Biotechnology has officially entered into a global strategic collaboration with Astellas Pharma. The agreement focuses on the co-development and... Read more

Category: Uncategorized

Tags: #M&A